The Hang Seng Tech Index continued its recovery rally on Wednesday, joining other global indices like the Nikkei 225 and the ...

The Caixin China General Services PMI unexpectedly advanced to 51.4 in February 2025, up from January’s four-month low of ...

Tesla (NASDAQ:TSLA) is offering an 8,000 yuan ($1101.08) insurance subsidy on purchases of Model 3 vehicles in China in a bid ...

JD.com (NASDAQ:JD) is set to report Q4 earnings on Thursday and investors will keep an eye on the e-commerce company’s retail sales data in China as favorable Chinese government stimulus measures ...

(RTTNews) - The China stock market on Wednesday ended the ... 188.04 points or 0.43 percent to finish at 43,433.12, while the NASDAQ added 48.88 points or 0.26 percent to close at 19,075.26 ...

It's liquidity that moves markets.” This chart of China’s money supply says it all. Image Source: Zacks Investment Research As billionaire investing legend David Tepper explained in a recent ...

(RTTNews) - The China stock market bounced higher again ... The Dow gained 71.25 points or 0.16 percent to finish at 44,627.59, while the NASDAQ rose 14.99 points or 0.07 percent to close at ...

The approval of tenapanor in China underlines the company's reliance ... Feb. 26, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to ...

(RTTNews) - China Yuchai International (CYD ... and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...

Despite the promising initial reviews in China, Tesla faces robust competition ... of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew ...

Feb. 20, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD ... for review by the Center for Drug Evaluation of China National Medical Products Administration.

SAN FRANCISCO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the sale of its China subsidiary to AstraZeneca for approximately $160 million. “Today ...